Unique ID issued by UMIN | UMIN000040582 |
---|---|
Receipt number | R000046312 |
Scientific Title | A randomized controlled trial about the efficacy of colorectal ESD using a scissors-type knife with traction device for early colorectal neoplasms |
Date of disclosure of the study information | 2020/05/29 |
Last modified on | 2023/12/01 09:27:45 |
A randomized controlled trial about the efficacy of colorectal ESD using a scissors-type knife with traction device for early colorectal neoplasms
RCT about the efficacy of colorectal ESD using a scissors-type knife with traction device
A randomized controlled trial about the efficacy of colorectal ESD using a scissors-type knife with traction device for early colorectal neoplasms
RCT about the efficacy of colorectal ESD using a scissors-type knife with traction device
Japan |
Early colorectal neoplasm
Gastroenterology |
Malignancy
NO
To comparare about efficacy and safety of ESD using a scissors-type knife with traction device to without traction device for early colorectal neoplasms
Safety,Efficacy
the resected specimen area to the procedure time
Resection Time
En bloc resection rate
Complete resection rate
Curative resection rate
Complication rate
One-year residual recurrence rate
Incidence of damage to resected specimens due to traction devices
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Device,equipment |
Group A: C (Conventional)-ESD
Group B: T (Traction)-ESD
20 | years-old | <= |
90 | years-old | >= |
Male and Female
(1) Lesions for which en bloc resection with snare EMR isdifficult to apply and tumor size is 20 to 50 mm.
(2) Aged 20 to 90 years old.
(3) PS (ECOG) performance status of 0,1or2.
(4) Without regard to gender.
(5) Patients taking one antithrombotic drug.
(6) Written informed consent
(1) preorerative endoscopic diagnosis of tumor depth is cT1b(SM2).
(2) The morphology of tumor is protruded.
(3) Lesions of local recurrence after endoscopic resection.
(4) Familial adenomatous polyposis and Inflamatory bowel disease.
(5) Patients taking more than two kinds of antithrombotic drugs.
(6) Patients with thrombocytopenia and/or bleeding tendency.
(7) Women during pregnancy.
(8) Patients enrolled in this study.
(9) Unsuitable patient for clinical trial judged by clinicians.
90
1st name | Toshio |
Middle name | |
Last name | Kuwai |
National Hospital Organization Kure Medical Center and Chugoku Cancer Center
Department of Gastroenterology
737-0023
3-1 Aoyama-cho, Kure, Japan
+81-823-22-3111
kuwai.toshio.ur@mail.hosp.go.jp
1st name | Yuzuru |
Middle name | |
Last name | Tamaru |
National Hospital Organization Kure Medical Center and Chugoku Cancer Center
Department of Gastroenterology
737-0023
3-1 Aoyama-cho, Kure, Japan
+81-823-22-3111
tamaru.yuzuru.vh@mail.hosp.go.jp
Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center
none
Self funding
Department of Gastroenterology, National Hospital Organization Kure Medical Center and Chugoku Cancer Center
3-1 Aoyama-cho, Kure, Japan
+81-823-22-3111
tamaru.yuzuru.vh@mail.hosp.go.jp
NO
2020 | Year | 05 | Month | 29 | Day |
Partially published
100
Completed
2020 | Year | 05 | Month | 29 | Day |
2020 | Year | 07 | Month | 10 | Day |
2020 | Year | 08 | Month | 01 | Day |
2023 | Year | 07 | Month | 31 | Day |
2020 | Year | 05 | Month | 29 | Day |
2023 | Year | 12 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046312